// App-Quantinova.ai

TCT-344 : Clinical Outcomes of Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients Stratified by STS Score: Results from the SURTAVI Trial

Researchers

Presenter

  • Patrick Serruys

Principal Investigators

  • Mohammad Abdelghani

  • Jeffrey J. Popma

  • Michael J. Reardon

  • Neal Kleiman

  • Juan Crestanello

  • Scott Lillly

  • Ad Van Boven

  • Piet Willem Boonstra

  • Nicolo Piazza

  • Nicolas Van Mieghem

  • A. Pieter Kappetein

Medical Centers

  • McGill University Health Centre, Montreal, QC, Canada

  • Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, United States

  • Medisch Centrum Leeuwarden, Heart Center, Leeuwarden, Netherlands

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • The Ohio State University, Columbus, Ohio, United States

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Imperial College, London, United Kingdom

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Locations

  • Canada

  • United States

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Preterm premature rupture of the membranes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final